Both CLN5 mouse and sheep models provide strong face validity for aspects of disease progression and sheep have already proved useful in development of a gene therapy strategy for CLN5 Batten disease. The gene discussed is CLN5; the disease is juvenile neuronal ceroid lipofuscinosis.